{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:48:22Z","timestamp":1793504902151,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.prp.2024.155534","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T22:34:20Z","timestamp":1723502060000},"page":"155534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Participation of T cells in generating immune protection against cancers"],"prefix":"10.1016","volume":"262","author":[{"given":"Anisha Singha","family":"Deo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shrijana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthika","family":"S.U","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Karun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashish","family":"Bisaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koustav","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.prp.2024.155534_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22900","article-title":"The current knowledge concerning solid cancer and therapy","volume":"35","author":"Najafi","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.prp.2024.155534_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104353","article-title":"Targeting regulatory T cells by curcumin: a potential for cancer immunotherapy","volume":"147","author":"Shafabakhsh","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.coi.2010.01.020","article-title":"Adoptive T cell therapy of cancer","volume":"22","author":"Brenner","year":"2010","journal-title":"Curr. Opin. Immunol."},{"issue":"12","key":"10.1016\/j.prp.2024.155534_bib4","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","article-title":"The central role of CD4(+) T cells in the antitumor immune response","volume":"188","author":"Hung","year":"1998","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.prp.2024.155534_bib5","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1172\/JCI32446","article-title":"Adoptive T cell therapy for cancer in the clinic","volume":"117","author":"June","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7150\/ijbs.7.651","article-title":"Dual roles of immune cells and their factors in cancer development and progression","volume":"7","author":"Zamarron","year":"2011","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2024.155534_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T Cell Dysfunction in Cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.prp.2024.155534_bib8","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.3390\/cancers15194771","article-title":"Dual functions of T lymphocytes in breast carcinoma: from immune protection to orchestrating tumor progression and metastasis","volume":"15","author":"Zareinejad","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.prp.2024.155534_bib9","first-page":"158","article-title":"Breast cancer and the immune system","volume":"6","author":"Standish","year":"2008","journal-title":"J. Soc. Integr. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2024.155534_bib10","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.7150\/ijbs.70120","article-title":"CAR-T cell therapy for breast cancer: from basic research to clinical application","volume":"18","author":"Yang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2024.155534_bib11","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8829.1","article-title":"An overview of cutaneous T cell lymphomas","volume":"5","author":"Bagherani","year":"2016","journal-title":"F1000Research"},{"issue":"17","key":"10.1016\/j.prp.2024.155534_bib12","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.18632\/oncotarget.3837","article-title":"Malignant T cells express lymphotoxin \u03b1 and drive endothelial activation in cutaneous T cell lymphoma","volume":"6","author":"Lauenborg","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.prp.2024.155534_bib13","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.3390\/cells10123376","article-title":"The role of T cell immunotherapy in acute myeloid leukemia","volume":"10","author":"Hao","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","volume":"3","author":"Di Pasquale","year":"2015","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.1700290106","article-title":"Immunological notes. xvii\u2013xxiv","volume":"29","author":"Glenny","year":"1926","journal-title":"J. Pathol. Bacteriol."},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/14760584.6.5.685","article-title":"Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation","volume":"6","author":"Hem","year":"2007","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.prp.2024.155534_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin. Immunol."},{"issue":"9","key":"10.1016\/j.prp.2024.155534_bib18","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4161\/onci.21971","article-title":"Licensing of \u03b3\u03b4T cells for professional antigen presentation: a new role for antibodies in regulation of antitumor immune responses","volume":"1","author":"Anderson","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.prp.2024.155534_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2051-1426-2-7","article-title":"Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy","volume":"2","author":"Schaer","year":"2014","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib20","first-page":"81","article-title":"CD8: adhesion molecule, co-receptor and immuno-modulator","volume":"1","author":"Cole","year":"2004","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.prp.2024.155534_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104353","article-title":"Targeting regulatory T cells by curcumin: a potential for cancer immunotherapy","volume":"147","author":"Shafabakhsh","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.prp.2024.155534_bib22","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","article-title":"The central role of CD4(+) T cells in the antitumor immune response","volume":"188","author":"Hung","year":"1998","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.prp.2024.155534_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrc.2016.97","article-title":"Engineered T cells: the promise and challenges of cancer immunotherapy","volume":"16","author":"Fesnak","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccell.2020.06.013","article-title":"Cytotoxic CD4+ T cells in bladder cancer-a new license to kill","volume":"38","author":"Sacher","year":"2020","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.prp.2024.155534_bib25","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.1073\/pnas.96.15.8633","article-title":"CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma","volume":"96","author":"Mumberg","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccell.2020.06.013","article-title":"Cytotoxic CD4+ T cells in bladder cancer-a new license to kill","volume":"38","author":"Sacher","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2024.155534_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.coi.2015.03.007","article-title":"Regulation of human helper T cell subset differentiation by cytokines","volume":"34","author":"Schmitt","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.prp.2024.155534_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4\u207aT cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.prp.2024.155534_bib29","article-title":"The role of TH17-associated cytokines in health and disease","volume":"2014","author":"O'Connor","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.prp.2024.155534_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8+ T cell exhaustion in cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2024.155534_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fimmu.2020.00702","article-title":"Prolonged persistence of chimeric antigen receptor (CAR) T cell in adoptive cancer immunotherapy: challenges and ways forward","volume":"11","author":"Jafarzadeh","year":"2020","journal-title":"Front. Immunol."},{"issue":"S1","key":"10.1016\/j.prp.2024.155534_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ajh.25418","article-title":"An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer","volume":"94","author":"Feins","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0198-8859(00)00223-8","article-title":"TCR stimulation protects CD8+ T cells from CD95 mediated apoptosis","volume":"62","author":"Karas","year":"2001","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.prp.2024.155534_bib35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib36","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1172\/JCI80445","article-title":"TIGIT and PD-1 impair tumor antigen-specific CD8\u207a T cells in melanoma patients.","volume":"125","author":"Chauvin","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1158\/0008-5472.CAN-16-2684","article-title":"CD39 expression defines cell exhaustion in tumor-infiltrating CD8+ T cells","volume":"78","author":"Canale","year":"2018","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.20160485","article-title":"The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment","volume":"214","author":"Williams","year":"2017","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.prp.2024.155534_bib39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20171068","article-title":"4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses","volume":"215","author":"Menk","year":"2018","journal-title":"J. Exp. Med."},{"issue":"1-3","key":"10.1016\/j.prp.2024.155534_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.febslet.2004.07.083","article-title":"PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70\/CD3zeta signalosome and downstream signaling to PKCtheta.","volume":"574","author":"Sheppard","year":"2004","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","article-title":"The transcription factor NFAT promotes exhaustion of activated CD8\u207a T cells","volume":"42","author":"Martinez","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.prp.2024.155534_bib42","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.prp.2024.155534_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41590-018-0045-y","article-title":"Metabolic exhaustion in infection, cancer and autoimmunity","volume":"19","author":"McKinney","year":"2018","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.prp.2024.155534_bib46","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood-2012-03-416040","article-title":"Human regulatory T cells induce T-lymphocyte senescence","volume":"120","author":"Ye","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41467-017-02689-5","article-title":"Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.prp.2024.155534_bib48","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.15252\/emmm.201403918","article-title":"TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence","volume":"6","author":"Ye","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib49","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/eji.201445312","article-title":"Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathways","volume":"45","author":"Henson","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.prp.2024.155534_bib50","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1172\/JCI70355","article-title":"p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes","volume":"123","author":"Mondal","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.prp.2024.155534_bib51","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1172\/JCI75051","article-title":"p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8\u207a T cells.","volume":"124","author":"Henson","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.prp.2024.155534_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fimmu.2018.00014","article-title":"Recent advances in targeting CD8 T-cell immunity for more effective cancer immunotherapy","volume":"9","author":"Durgeau","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2024.155534_bib54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.prp.2024.155534_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4\u207aT cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.prp.2024.155534_bib56","series-title":"Immunobiology: The Immune System in Health and Disease","author":"Janeway","year":"2001"},{"key":"10.1016\/j.prp.2024.155534_bib57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fimmu.2014.00575","article-title":"\u03b3\u03b4\u2009T lymphocytes as a first line of immune defense: old and new ways of antigen recognition and implications for cancer immunotherapy","volume":"5","author":"Poggi","year":"2014","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.prp.2024.155534_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2023.110724","article-title":"Function of gamma delta (\u03b3\u03b4) T cell in cancer with special emphasis on cervical cancer","volume":"84","author":"Patra","year":"2023","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib59","first-page":"236","article-title":"Natural killer T cells in health and disease","volume":"3","author":"Wu","year":"2011","journal-title":"Front. Biosci. (Sch. Ed. )"},{"key":"10.1016\/j.prp.2024.155534_bib60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fimmu.2018.00367","article-title":"The role of natural killer T cells in cancer-a phenotypical and functional approach","volume":"9","author":"Krijgsman","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2024.155534_bib63","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3389\/fimmu.2020.01013","article-title":"Metabolic Reprogramming in CD8+ T cells during acute viral infections","volume":"11","author":"Gupta","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.prp.2024.155534_bib64","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining 'T cell exhaustion","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib65","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.autrev.2008.12.019","article-title":"The role of innate immune responses in autoimmune disease development","volume":"8","author":"Waldner","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib66","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.autrev.2008.12.019","article-title":"The role of innate immune responses in autoimmune disease development","volume":"8","author":"Waldner","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib67","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ydbio.2006.05.006","article-title":"Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation","volume":"297","author":"Bates","year":"2006","journal-title":"Dev. Biol."},{"issue":"19","key":"10.1016\/j.prp.2024.155534_bib68","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1182\/blood-2011-07-365817","article-title":"Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?","volume":"118","author":"Ustun","year":"2011","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.prp.2024.155534_bib69","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120974","article-title":"Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy","volume":"3","author":"Knaus","year":"2018","journal-title":"JCI Insight"},{"issue":"25","key":"10.1016\/j.prp.2024.155534_bib70","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma","volume":"117","author":"Foss","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.prp.2024.155534_bib71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-pathol-020117-043821","article-title":"Pathogenesis of Peripheral T Cell Lymphoma","volume":"13","author":"Pizzi","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"7910","key":"10.1016\/j.prp.2024.155534_bib72","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-022-04682-5","article-title":"Landscape of helper and regulatory antitumour CD4+ T cells in melanoma","volume":"605","author":"Oliveira","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib73","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1258\/ebm.2011.011007","article-title":"Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity","volume":"236","author":"Jochems","year":"2011","journal-title":"Exp. Biol. Med. (Maywood, N. J. )"},{"issue":"29","key":"10.1016\/j.prp.2024.155534_bib74","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1038\/onc.2010.174","article-title":"Human FOXP3 and cancer","volume":"29","author":"Martin","year":"2010","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.prp.2024.155534_bib75","first-page":"197","article-title":"Vaccine adjuvants - current status and prospects on controlled release adjuvancity","volume":"19","author":"Sivakumar","year":"2011","journal-title":"Saudi Pharm. J.\u00a0SPJ\u00a0Off. Publ. Saudi Pharm. Soc."},{"issue":"4","key":"10.1016\/j.prp.2024.155534_bib76","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.prp.2024.155534_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0167-5699(89)90081-9","article-title":"Immunogenicity signals 1,2,3 \u2026 and 0","volume":"10","author":"Janeway","year":"1989","journal-title":"Immunol. Today"},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.prp.2024.155534_bib79","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.prp.2024.155534_bib80","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1176","article-title":"Recent advances in the discovery and delivery of vaccine adjuvants","volume":"2","author":"O'Hagan","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.prp.2024.155534_bib81","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib82","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.celrep.2017.07.027","article-title":"Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells","volume":"20","author":"Okada","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.prp.2024.155534_bib83","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.prp.2024.155534_bib84","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1074-7613(00)80480-X","article-title":"Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement","volume":"4","author":"Linsley","year":"1996","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.prp.2024.155534_bib85","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/eji.1830250949","article-title":"CD4\/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins","volume":"25","author":"Huard","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.prp.2024.155534_bib86","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41590-018-0217-9","article-title":"LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII","volume":"19","author":"Maruhashi","year":"2018","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.prp.2024.155534_bib87","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni988","article-title":"Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance","volume":"4","author":"Sabatos","year":"2003","journal-title":"Nat. Immunol."},{"issue":"42","key":"10.1016\/j.prp.2024.155534_bib88","doi-asserted-by":"crossref","first-page":"17858","DOI":"10.1073\/pnas.0903474106","article-title":"The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity","volume":"106","author":"Stanietsky","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.prp.2024.155534_bib89","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.1003081","article-title":"Cutting edge: TIGIT has T cell-intrinsic inhibitory functions","volume":"186","author":"Joller","year":"2011","journal-title":"J. Immunol. (Baltim.\u00a0Md.\u00a01950)"},{"issue":"8","key":"10.1016\/j.prp.2024.155534_bib90","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.prp.2024.155534_bib91","first-page":"79","article-title":"Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints","volume":"12","author":"Karachaliou","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.prp.2024.155534_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111548","article-title":"The role of dendritic cells in cancer immunity and therapeutic strategies","volume":"128","author":"Tai","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.prp.2024.155534_bib93","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/cancers13010134","article-title":"The role of antigen processing and presentation in cancer and the efficacy of immune checkpoint inhibitor immunotherapy.","volume":"13","author":"Mpakali","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155534_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.876339","article-title":"Impact of manufacturing procedures on CAR T cell functionality","volume":"13","author":"Watanabe","year":"2022","journal-title":"Front. Immunol."},{"issue":"26","key":"10.1016\/j.prp.2024.155534_bib95","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1182\/blood-2016-02-629063","article-title":"CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date","volume":"127","author":"Park","year":"2016","journal-title":"Blood"},{"issue":"47","key":"10.1016\/j.prp.2024.155534_bib96","first-page":"277","article-title":"Adoptive immunotherapy for B-cell malignancies with autologous chimeric antigen receptor modified tumor targeted T cells","volume":"9","author":"Park","year":"2010","journal-title":"Discov. Med."},{"issue":"224","key":"10.1016\/j.prp.2024.155534_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"177","key":"10.1016\/j.prp.2024.155534_bib98","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.prp.2024.155534_bib99","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.prp.2024.155534_bib100","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1182\/blood-2014-12-580068","article-title":"CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.prp.2024.155534_bib101","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2019.09.006","article-title":"Combination Immunotherapy with CAR T cells and checkpoint blockade for the treatment of solid tumors","volume":"36","author":"Grosser","year":"2019","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.prp.2024.155534_bib102","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41571-020-0347-5","article-title":"T cell-engaging therapies - BiTEs and beyond","volume":"17","author":"Goebeler","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2024.155534_bib103","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.drudis.2014.03.021","article-title":"Regeneration of stalled immune responses to transformed and infected cells using \u03b3\u03b4 T cells","volume":"19","author":"Gustafsson","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.prp.2024.155534_bib104","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/ijms20030586","article-title":"The potential of combining tubulin-targeting anticancer therapeutics and immune therapy","volume":"20","author":"Fong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.prp.2024.155534_bib105","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1158\/0008-5472.CAN-15-3130","article-title":"CD27 Agonism Plus PD-1 blockade recapitulates CD4+ T-cell help in therapeutic anticancer vaccination","volume":"76","author":"Ahrends","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2024.155534_bib106","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4161\/cc.9.4.10782","article-title":"Unexpected deeds of familiar proteins: Interplay of Hsp70, PGRP-S\/Tag7 and S100A4\/Mts1 in host vs. cancer combat","volume":"9","author":"Dukhanina","year":"2010","journal-title":"Cell Cycle (Georget., Tex. )"},{"issue":"4","key":"10.1016\/j.prp.2024.155534_bib107","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/vaccines11040835","article-title":"T Cell Based Immunotherapy for Cancer: approaches and strategies","volume":"11","author":"Want","year":"2023","journal-title":"Vaccines"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382400445X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382400445X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:55:36Z","timestamp":1727186136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382400445X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":107,"alternative-id":["S034403382400445X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155534","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Participation of T cells in generating immune protection against cancers","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155534"}}